Drug Profile
VAG 624
Alternative Names: VAG624Latest Information Update: 08 May 2006
Price :
$50
*
At a glance
- Originator Novartis
- Class Antiacnes
- Mechanism of Action Sulfatase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Acne
Most Recent Events
- 19 Nov 2003 Phase-I clinical trials in Acne in USA (unspecified route)